secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORASURE TECHNOLOGIES INC (OSUR)
CIK:        0001116463
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0000950170-22-025070
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

OraSure appoints Kathleen G. Weber Chief Product Officer; Lisa Nibauer resigns as President of Diagnostics
--------------------------------------------------------------------------------

- Kathleen G. Weber, previously President of Molecular Solutions, appointed as Chief Product Officer effective Nov 14, 2022.
- Amendment to employment agreement reflects title/duties change and updates definition of Good Reason; severance unchanged.
- Lisa Nibauer resigns as President of Diagnostics effective Nov 11, 2022.
- No details on resignation reason or immediate successor for Diagnostics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1116463/000095017022025070/0000950170-22-025070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1116463/000095017022025070/osur-20221107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-025070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer